1 – 10 of 11
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2023
- 
                        Mark
        A trans-omics assessment of gene–gene interaction in early-stage NSCLC
    
    - Contribution to journal › Article
 
- 2022
- 
                        Mark
        Epigenome-wide three-way interaction study identifies a complex pattern between TRIM27, KIAA0226, and smoking associated with overall survival of early-stage NSCLC
    
    - Contribution to journal › Article
 
- 2020
- 
                        Mark
        Epigenome-wide gene-age interaction analysis reveals reversed effects of PRODH DNA methylation on survival between young and elderly early-stage NSCLC patients
    
    - Contribution to journal › Article
 
- 
                        Mark
        Epigenetic–smoking interaction reveals histologically heterogeneous effects of TRIM27 DNA methylation on overall survival among early-stage NSCLC patients
    
    - Contribution to journal › Article
 
- 
                        Mark
        Independent Validation of Early-Stage Non-Small Cell Lung Cancer Prognostic Scores Incorporating Epigenetic and Transcriptional Biomarkers With Gene-Gene Interactions and Main Effects
    
    - Contribution to journal › Article
 
- 2019
- 
                        Mark
        EGLN2 DNA methylation and expression interact with HIF1A to affect survival of early-stage NSCLC
    
    - Contribution to journal › Article
 
- 
                        Mark
        Trans-omics biomarker model improves prognostic prediction accuracy for early-stage lung adenocarcinoma
    
    - Contribution to journal › Article
 
- 
                        Mark
        SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival : an epigenomic–smoking interaction analysis
    
    - Contribution to journal › Article
 
- 2018
- 
                        Mark
        DNA Methylation of LRRC3B : A Biomarker for Survival of Early-Stage Non-Small Cell Lung Cancer Patients
    (2018) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 27(12). p.1527-1535- Contribution to journal › Article
 
- 
                        Mark
        A multi-omic study reveals BTG2 as a reliable prognostic marker for early-stage non-small cell lung cancer
    
    - Contribution to journal › Article